IDEXX Laboratories Equity 2024

IDEXX Laboratories Aktienanalyse

What does IDEXX Laboratories do?

The history of IDEXX Laboratories Inc began in 1983 when a research team from the University of Maine developed technology for the automatic analysis of animal blood. The first products were soon sold and the company grew rapidly. Today, IDEXX is a leading global provider of veterinary diagnostic and IT solutions, recognized by customers in over 175 countries. IDEXX's business model is based on innovation and a comprehensive understanding of the needs of veterinarians and their patients. The company offers a wide range of products and solutions that make the diagnosis and treatment of animal diseases easier and more reliable. These include tests and devices for blood analysis, urine and stool diagnostics, as well as imaging, infection control, and cancer diagnostics. The company has several divisions that focus on different aspects of veterinary diagnostics. IDEXX Diagnostics is the largest business segment, offering veterinary lab services, diagnostic tests, and software solutions. IDEXX Water is a company specializing in the analysis of water samples and monitoring of environmental conditions. IDEXX Livestock, the newest division of IDEXX, provides veterinary solutions for agricultural and livestock operations. Key products of IDEXX include tests for parasites, infections, diabetes, and kidney function. The company has also developed some innovative products, such as SNAP tests, which provide fast and accurate results and can perform tests for various pathogens simultaneously. IDEXX is also a company committed to sustainability. The IDEXX Foundation was established in 2013 and has since donated over $32 million to local and global projects that aim to protect animals and the environment. Overall, IDEXX Laboratories Inc is a company specialized in veterinary diagnostic and IT solutions to support veterinarians in treating animals. The wide range of solutions and products, as well as the commitment to sustainability, make the company an important player in the market for veterinary diagnostics. IDEXX Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

IDEXX Laboratories revenue by segment

In the annual report of the IDEXX Laboratories share (US45168D1046, 888210, IDXX), it breaks down its revenues into 4 segments: 1. Companion Animal Group, 2. Water, 3. Livestock, Poultry & Dairy, 4. Other. The IDEXX Laboratories stock (WKN: 888210, ISIN: US45168D1046, Ticker Symbol: IDXX) is a leading investment for investors interested in participating in the Health Care sector.

88 % Companion Animal Group
6 % Water
5 % Livestock, Poultry & Dairy
1 % Other

Equity Details

Analyzing IDEXX Laboratories's Equity

IDEXX Laboratories's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding IDEXX Laboratories's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating IDEXX Laboratories's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

IDEXX Laboratories's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in IDEXX Laboratories’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about IDEXX Laboratories stock

What is the equity of IDEXX Laboratories this year?

IDEXX Laboratories has equity of 1.48 B USD this year.

What was the equity of IDEXX Laboratories compared to the previous year?

The equity of IDEXX Laboratories has increased/decreased by 143.89% increased compared to the previous year.

What impact does a high equity have on investors of IDEXX Laboratories?

A high equity is advantageous for investors of IDEXX Laboratories as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of IDEXX Laboratories?

A low equity can be a risk for investors of IDEXX Laboratories, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of IDEXX Laboratories affect the company?

An increase in equity of IDEXX Laboratories can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of IDEXX Laboratories affect the company?

A reduction in equity of IDEXX Laboratories can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of IDEXX Laboratories?

Some factors that can affect the equity of IDEXX Laboratories include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of IDEXX Laboratories so important for investors?

The equity of IDEXX Laboratories is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can IDEXX Laboratories take to change the equity?

To change equity, IDEXX Laboratories can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does IDEXX Laboratories pay?

Over the past 12 months, IDEXX Laboratories paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IDEXX Laboratories is expected to pay a dividend of 0 USD.

What is the dividend yield of IDEXX Laboratories?

The current dividend yield of IDEXX Laboratories is .

When does IDEXX Laboratories pay dividends?

IDEXX Laboratories pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of IDEXX Laboratories?

IDEXX Laboratories paid dividends every year for the past 0 years.

What is the dividend of IDEXX Laboratories?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is IDEXX Laboratories located?

IDEXX Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von IDEXX Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IDEXX Laboratories from 8/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/17/2024.

When did IDEXX Laboratories pay the last dividend?

The last dividend was paid out on 8/17/2024.

What was the dividend of IDEXX Laboratories in the year 2023?

In the year 2023, IDEXX Laboratories distributed 0 USD as dividends.

In which currency does IDEXX Laboratories pay out the dividend?

The dividends of IDEXX Laboratories are distributed in USD.